<DOC>
	<DOCNO>NCT00542243</DOCNO>
	<brief_summary>The purpose study ass whether six month daily finasteride ( PROSCAR ) , follow initial negative prostate biopsy , improve detection prostate cancer repeat biopsy . 144 subject initial negative prostate biopsy randomize receive either finasteride placebo 6 month . The subject undergo second prostate biopsy follow drug intervention . PSA ( prostate specific antigen ) measurement , testosterone level , quality life questionnaire also assess study . The two group compare .</brief_summary>
	<brief_title>A Trial PROSCAR ( Finasteride ) Versus Placebo Men With Initial Negative Prostate Biopsy</brief_title>
	<detailed_description>5.0 . Study Design Treatment 5.1 . Study Design This randomize , two-arm , double blind , placebo control study daily PROSCARÂ® placebo 6 month men initial negative prostate biopsy . 5.1.1 . Biopsy The TRUS guide biopsy , carry Visit 4 , perform one physician . The biopsy perform per standard protocol UHN , include 13-15 core . The physician performing biopsy blind initial biopsy result PSA change time . Before biopsy , DRE perform . Aside standard biopsy scheme , suspicious area TRUS biopsied . ( e.g . hypoechoic nodule ) . 5.2 . Methods Accrual Randomization : Patients initial negative prostate biopsy perform UHN see Prostate Center Princess Margaret Hospital consider enrolment . Randomization random number table perform block 4 patient . After patient deem eligible study , central office Merck contact patient assignment give . The code match study drug label drug shipment contain blind allocation envelope . The investigator , study participant research coordinator blind intervention .</detailed_description>
	<mesh_term>Finasteride</mesh_term>
	<criteria>Initial biopsy , perform UHN , least 8 core evidence cancer ( HGPIN ASAP allow ) PSA &lt; 20 ng/ml Able swallow retain oral medication Able read write ( IPSS questionnaire selfadministered ) , understand instruction relate study procedure give write informed consent . Glucocorticoids , except inhaled topical , permit within 3 month prior visit one . Concurrent previous use within past 12 month follow medication : Finasteride ( PROSCAR , Propecia ) , Dutasteride ( Avodart ) , Any investigational 5 alphareductase inhibitor , Anabolic steroid , drug antiandrogenic property . Participation investigational market drug trial within 30 day prior first dose study drug anytime study period . Abnormal liver function test ( great 2 time upper limit normal ) alanine aminotransferase , aspartate aminotransferase , alkaline phosphatase ; bilirubin &gt; 1.5 time upper limit normal . Serum creatinine &gt; 1.5 time upper limit normal . Any unstable serious coexist medical condition include limited myocardial infarction , coronary bypass surgery , unstable angina , cardiac arrhythmia , clinically evident congestive heart failure , cerebrovascular accident within 6 month prior screen visit ; uncontrolled diabetes peptic ulcer disease uncontrolled medical management . History illness ( include psychiatric ) , opinion investigator , might confound result study pose additional risk subject . Known hypersensitivity 5 alphareductase inhibitor drug chemically related finasteride .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>enlarge prostate</keyword>
	<keyword>finasteride</keyword>
</DOC>